BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26590805)

  • 1. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Purohit S; Kumar V; Sharma A; Fatima R; Topno AP; Shaha C; Suri A
    J Exp Clin Cancer Res; 2015 Nov; 34():142. PubMed ID: 26590805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer.
    Gupta N; Jagadish N; Surolia A; Suri A
    Am J Cancer Res; 2017; 7(6):1252-1269. PubMed ID: 28670489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
    Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
    Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.
    Wu S; Wu F; Jiang Z
    Int J Oncol; 2018 Jun; 52(6):2093-2100. PubMed ID: 29620285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
    Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
    Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
    Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
    BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of A-Kinase Anchor Protein 4 (AKAP4) Inhibits Proliferation and Progression of Thyroid Cancer.
    Han J; Gao W; Su D; Liu Y
    Oncol Res; 2017 Jul; 25(6):873-878. PubMed ID: 27983916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.
    Lin K; Jiang H; Zhang LL; Jiang Y; Yang YX; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
    Dig Dis Sci; 2018 Sep; 63(9):2320-2331. PubMed ID: 29808247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers.
    Tavakoli Koudehi A; Mahjoubi B; Mirzaei R; Shabani S; Mahjoubi F
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):463-469. PubMed ID: 29480665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo.
    Saini S; Agarwal S; Sinha A; Verma A; Parashar D; Gupta N; Ansari AS; Lohiya NK; Jagadish N; Suri A
    Cancer Gene Ther; 2013 Jul; 20(7):413-20. PubMed ID: 23764900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of long non-coding RNA-CTD903 inhibits colorectal cancer invasion and migration by repressing Wnt/β-catenin signaling and predicts favorable prognosis.
    Yuan Z; Yu X; Ni B; Chen D; Yang Z; Huang J; Wang J; Chen D; Wang L
    Int J Oncol; 2016 Jun; 48(6):2675-85. PubMed ID: 27035092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer.
    Thorenoor N; Faltejskova-Vychytilova P; Hombach S; Mlcochova J; Kretz M; Svoboda M; Slaby O
    Oncotarget; 2016 Jan; 7(1):622-37. PubMed ID: 26506418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway.
    Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z
    Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
    Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
    Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
    Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
    Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.